Allergy & Asthma Network Mothers of Asthmatics (AANMA) maintains a listing of clinical research trials for adults and children with asthma and allergies. Check back frequently for new clinical trials in your area.

AANMA does not endorse any company or product on this list. If you are interested in participating in a clinical trial, we advise you to talk with your physician first.

Do not contact AANMA with questions about a clinical trial posted on this site; call the phone number listed in the specific study instead.

If you have an IRB-approved clinical trial you would like AANMA to post, contact us.

---

EXPECT Pregnancy Registry: An Observational Research Study of the Use and Safety of XOLAIR^® (Omalizumab) During Pregnancy

Purpose of the study

This is an observational Pregnancy Registry to evaluate pregnancy outcomes in pregnant women who have taken XOLAIR before and/or during pregnancy. Participants will take part in a telephone interview each trimester, at the time of delivery, and when the baby turns 1 year old. No clinic visits are required. Mothers who continue to take XOLAIR while breastfeeding will be asked to participate in one more telephone interview when the baby is 18 months old. Eligible participants will be compensated for each telephone interview.

You do not have to be taking XOLAIR currently to enroll!

Eligible Participants

• Women who are pregnant AND
• Who have received Xolair before or during pregnancy

Principal investigator:

John M. Thorp Jr., MD

University of North Carolina at Chapel Hill

For more information or to enroll:

Call 866-4XOLAIR (496-5247), option 3

Visit www.xolairpregnancyregistry.com